Microcap Stock Monster
This under-the-radar stock is ready to explode for one big reason.
Get the info now.

FHTX Insider Trading (Foghorn Therapeutics)

Insider Ownership Percentage: 16.12%
Insider Buying (Last 12 Months): $2,488,000.00
Insider Selling (Last 12 Months): $0.00

Foghorn Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Foghorn Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Foghorn Therapeutics Share Price & Price History

Current Price: $12.64
Price Change: Price Increase of +0.25 (2.02%)
As of 10/22/2021 04:14 PM ET

This chart shows the closing price history over time for FHTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This Tech Stock Is Disruptive
This stock is ready to go vertical! It could win tech innovation of the year.
Learn more

Foghorn Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/27/2020Abu Dhabi Investment AuthorityMajor ShareholderBuy150,000$16.00$2,400,000.00View SEC Filing Icon  
10/27/2020Carl DeciccoInsiderBuy5,500$16.00$88,000.00258,397View SEC Filing Icon  
See Full Table
Insider Buying at Foghorn Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Foghorn Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Foghorn Therapeutics (NASDAQ:FHTX)

63.38% of Foghorn Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FHTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Foghorn Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/23/2021Morgan Stanley980,209$10.46M0.0%+149.0%2.654%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC195,762$2.09M0.0%+20.8%0.530%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE12,270$0.13M0.0%+126.8%0.033%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System26,977$0.29M0.0%+148.0%0.073%Search for SEC Filing on Google Icon
8/16/2021Royal Bank of Canada2,588$27K0.0%+102.3%0.007%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley980,209$10.46M0.0%+149.0%2.654%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.71,361$0.76M0.0%+49.9%0.193%Search for SEC Filing on Google Icon
8/16/2021State Street Corp189,399$2.02M0.0%+73.6%0.513%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC56,410$0.60M0.0%+377.8%0.153%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp162,900$1.74M0.0%+93.2%0.441%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC237,744$2.54M0.0%+62.1%0.645%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.683,778$7.30M0.0%+67.9%1.856%Search for SEC Filing on Google Icon
8/13/2021FMR LLC2,540,434$27.11M0.0%-1.3%6.895%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.26,235$0.28M0.0%+31.1%0.071%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp51,419$0.55M0.0%+164.5%0.140%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.1,093,860$11.67M0.0%+153.1%2.969%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG189,109$2.02M0.0%-15.2%0.513%Search for SEC Filing on Google Icon
8/5/2021Rhumbline Advisers15,659$0.17M0.0%N/A0.042%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund16,758$0.18M0.0%+308.7%0.045%Search for SEC Filing on Google Icon
5/19/2021Octagon Capital Advisors LP69,132$0.91M0.3%N/A0.188%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC162,118$2.14M0.0%-24.5%0.440%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.109,200$1.44M0.0%N/A0.296%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley393,722$5.19M0.0%+821.1%1.069%Search for SEC Filing on Google Icon
5/17/2021Suvretta Capital Management LLC84,000$1.11M0.0%-67.5%0.228%Search for SEC Filing on Google Icon
5/14/2021Monashee Investment Management LLC530,581$6.99M1.1%-5.3%1.441%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp19,440$0.26M0.0%+7.5%0.053%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp84,296$1.11M0.0%-4.7%0.229%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC146,640$1.93M0.0%+10.7%0.398%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.432,125$5.70M0.0%-35.7%1.173%Search for SEC Filing on Google Icon
5/4/2021Victory Capital Management Inc.16,190$0.21M0.0%-82.6%0.044%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP27,939$0.57M0.0%N/A0.076%Search for SEC Filing on Google Icon
2/25/2021Hsbc Holdings PLC18,900$0.39M0.0%N/A0.053%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.19,639$0.40M0.0%N/A0.055%Search for SEC Filing on Google Icon
2/16/2021Flagship Pioneering Inc.12,674,120$256.91M4.7%N/A35.389%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC11,807$0.24M0.0%N/A0.033%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.45,956$0.93M0.0%N/A0.128%Search for SEC Filing on Google Icon
2/13/2021American International Group Inc.4,181$85K0.0%N/A0.012%Search for SEC Filing on Google Icon
2/12/2021Caas Capital Management LP15,000$0.30M0.0%N/A0.042%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp88,438$1.79M0.0%N/A0.247%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.1,329$27K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/11/2021Artal Group S.A.1,720,720$34.88M0.7%N/A4.805%Search for SEC Filing on Google Icon
2/11/2021Monashee Investment Management LLC560,360$11.36M1.5%N/A1.565%Search for SEC Filing on Google Icon
2/10/2021Board of Trustees of The Leland Stanford Junior University30,657$0.62M0.0%N/A0.086%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN3,747$76K0.0%N/A0.010%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp18,086$0.37M0.0%N/A0.050%Search for SEC Filing on Google Icon
2/8/2021New York State Common Retirement Fund4,100$83K0.0%N/A0.011%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.672,204$13.63M0.0%N/A1.877%Search for SEC Filing on Google Icon
2/1/2021Victory Capital Management Inc.93,070$1.89M0.0%N/A0.260%Search for SEC Filing on Google Icon
1/30/2021Fiduciary Trust Co.10,879$0.22M0.0%N/A0.030%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia; and FHD-609, a small molecule protein degrader of BRD9 to treat patients with synovial sarcoma. The company is also developing an enzymatic inhibitor and a protein degrader as selective modulators of BRM; and ARID1B selective modulators for the treatment of ovarian, endometrial, colorectal, bladder, and gastric cancers. Foghorn Therapeutics Inc. has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel therapeutics based on disruptors of a specified transcription factor target. The company was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Read More on Foghorn Therapeutics

Today's Range

Now: $12.64
Low: $11.91
High: $12.91

50 Day Range

MA: $12.41
Low: $8.33
High: $15.02

52 Week Range

Now: $12.64
Low: $8.01
High: $28.26

Volume

750 shs

Average Volume

50,219 shs

Market Capitalization

$466.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Foghorn Therapeutics?

Foghorn Therapeutics' top insider investors include:
  1. Carl Decicco (Insider)
  2. Abu Dhabi Investment Authority (Major Shareholder)
Microcap Stock Monster
This under-the-radar stock is ready to explode for one big reason.
Get the info now.